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Abstract The copper-containing plasma protein caeruloplasmin
(Cp) has been shown to possess several oxidase activities, but
with the exception of its ferrous ion oxidising (ferroxidase)
activity which so far appear to be of minor biological relevance.
Recently, Kim and colleagues (Kim et al. (1998) FEBS Lett. 431,
pp. 473^475) observed that Cp can catalytically remove
hydrogen peroxide in the presence of thiols. Here, we show that
Cp can remove both hydrogen peroxide and lipid hydroperoxides
at physiologically relevant concentrations of reduced glutathione
known to be present in lung and lung lining fluid. The glutathione
peroxidase-like activity of Cp together with its ferroxidase
activity would completely remove the primary reactants required
for both Fenton chemistry and lipid peroxidation.
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1. Introduction
The major copper-containing protein of normal human
plasma is caeruloplasmin (Cp), an acute-phase protein with
several oxidase activities (reviewed in [2]) that is synthesised in
the liver, although several other tissues can also make the
protein [3^5]. In spite of an intensive research interest in
Cp, its biological functions remain an enigma. The protein
is able to catalyse the oxidation of ferrous ions to the less
reactive ferric state (ferroxidase activity) [6,7]. This observa-
tion led us several years ago to propose that Cp functions as
an important plasma antioxidant when redox active iron is
involved in molecular damage [8^9]. Cp contains six tightly
bound copper atoms and one loosely associated with the pro-
tein which can be removed by chelation (reviewed in [2]). It
has recently been suggested that native Cp carries this seventh
copper and that this copper makes Cp pro-oxidant towards
the oxidation of low density lipoproteins [10]. Debate con-
cerning the pro-oxidant properties of copper associated with
Cp continues, however (reviewed in [11]).
Recently, Kim and colleagues observed that Cp destroys
hydrogen peroxide (H2O2) when thiols are present [1]. Here,
we extend this ¢nding to show that Cp can remove H2O2 and
lipid hydroperoxides (LOOH) at concentrations of reduced
glutathione (GSH) reported as present in lung tissue [12]
and lung lining £uid [12^15]. The lung has recently been iden-
ti¢ed as an important site of Cp synthesis in primates [16]
with the protein, subsequently, entering lung lining £uid
[16]. Lung lining £uid also contains a mixture of the selenium-
containing extracellular glutathione peroxidase (EC-
GSHPase) and cellular glutathione peroxidase (C-GSHPase)
[17] with the former predominating [17]. Since EC-GSHPase
requires GSH in the mM range [18] for its activity, Cp may be
the more important protein for removing peroxides in lung
lining £uid.
2. Materials and methods
2.1. Materials
Cp, linolenic acid, GSH, conalbumin (egg white apotransferrin) and
horseradish peroxidase (HRP) were obtained from Sigma (MO,
USA). Myeloperoxidase (MPO), 5,5P-dinitro-bis-(2-nitrobenzoic
acid) (DTNB), taurine, trichloroacetic acid (TCA), potassium thiocya-
nate (KSCN), FeSO4W7H2O, HEPES and sodium hypochlorite
(HOCI) were purchased from Wako (Osaka, Japan), Sephadex G25
was from Pharmacia (Uppasla, Sweden) and Amplex Red (N-acetyl-3-
7-dihydroxyphenoxazine) was obtained from Molecular Probes (OR,
USA).
2.2. Puri¢cation of human Cp
Cp obtained as a solution (50 mg/ml) was further puri¢ed by pass-
ing it through a column of Sephadex G25 and eluting with 50 mM
sodium phosphate bu¡er (pH 7.4). The protein concentration was
determined with the Bradford method using bovine serum albumin
as a standard.
2.3. Preparation of LOOHs
A thin ¢lm layer of methyl linolenic acid was formed on the inner
surface of a £ask by rotation [19]. This was allowed to auto-oxidise in
air at 37‡C. After 48 h, it was suspended in methanol and used with-
out further puri¢cation. The amount of hydroperoxide present was
calculated from the UV absorption at 234 nm (O= 27 400 M31 cm31).
2.4. Measurement of thiol-linked peroxidase activities
2.4.1. Hydrogen peroxide. The peroxidase activity of Cp was de-
termined by two methods using KSCN [20] and a £uorescence probe
[21]. The reaction was started by addition of 500 WM H2O2 into a 50 Wl
reaction mixture containing 0.5^500 WM GSH, 50 mM HEPES bu¡er
(pH 7.0) and an appropriate amount of sample, for incubation at
37‡C. After 40 min, the 40 Wl reaction mixture was added to 0.8 ml
TCA solution to stop the reaction, followed by addition of 200 Wl
10 mM FeSO4 and 100 Wl KSCN to develop the purple colour. Meas-
urement of the remaining H2O2 was performed by monitoring the
decrease in absorbance at 480 nm. A 10 Wl residue was assayed by
the £uorescence method using an Amplex Red probe. Amplex Red,
10 WM, was incubated with the reaction mixture and 1 U/ml HRP in
50 mM Tris, pH 7.4, at room temperature for 5 min before a 10-fold
dilution prior to measurement. The £uorescence intensity of the re-
action mixture was measured using a £uorescence microplate reader
with a ¢lter set for excitation and emission at 560 and 595 nm, re-
spectively (Biolumin 960, Molecular Dynamic).
2.4.2. LOOHs. The reaction was started by addition of 180 WM
LOOH into 50 Wl of the reaction mixture containing 0.5^500 WM
HEPES bu¡er (pH 7.0) and an appropriate amount of sample for
incubation at 37‡C. After 40 min, the remaining hydroperoxide was
determined as above using the KSCN method.
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2.5. Measurement of ferroxidase activity of Cp
Ferroxidase activity of Cp was assayed by measuring the oxidation
of ferrous ions to the ferric state, at pH 5.5. Ferric ions bind to
apotransferrin to produce a pink complex (A460 nm) [22]. In this assay,
conalbumin (egg white apotransferrin) was substituted for apotrans-
ferrin.
2.6. Measurement of hypochlorous acid formation
Generation of HOCI was determined as taurine-chloramine forma-
tion [23]. 1 mM thio-bis-(2-nitrobenzoic acid) (TNB) was prepared by
dissolving 2 mM DTNB in 50 mM phosphate bu¡er, pH 7.4. The
solution of DTNB was titrated to pH 12.0 with sodium hydroxide to
promote its hydrolysis and after 5 min, the pH was brought back to
pH 7.4 with hydrochloric acid. Reactions were started by adding
H2O2, Cp and NaCI in bu¡er containing 10 mM taurine and incu-
bated for 10 min at 37‡C. TNB was added to the sample solution and
incubated for 5 min. The A412 nm was determined and the amount of
HOCI generated was calculated from a standard curve using aliquots
of 10 mM taurine bu¡er to which known amounts of HOCI (A292 nm
O= 350 M31 cm31) were added.
3. Results and discussion
Intact human Cp has recently been ascribed a thiol-linked
peroxidase activity [1] which we here show can remove H2O2
and LOOH at physiologically relevant concentrations of GSH
(Figs. 1 and 2) known to be present in lung tissue [12] and
lung lining £uid [12^15]. GSH at ¢nal reaction concentrations
of 50^500 WM supported the peroxidase activities of Cp.
Whilst H2O2 was being removed, chloride ions enhanced the
peroxidase activity as previously observed [1], but made no
Fig. 1. GSH-dependent removal of H2O2 by Cp. 10 WM Cp (65 Wg)
and 500 WM H2O2 were incubated with various GSH concentrations
for 40 min. The peroxidase activities were assayed by the KSCN
method. The amount of hydrogen peroxide removed was calculated
from a standard curve using known amounts of H2O2. Data are
means þ S.D. of triplicate experiments.
Fig. 2. GSH-dependent removal of LOOH by Cp. 10 WM Cp and
180 WM hydroperoxide were incubated with various GSH concentra-
tions for 40 min. The peroxidase activities were assayed by the
KSCN method. The amount of hydroperoxide removed was calcu-
lated from a standard curve using known amounts of LOOH that
were added. Data are means þ S.D. of triplicate experiments.
Fig. 3. The e¡ect of chloride ions on peroxide removal (H2O2 and
LOOH). Reaction conditions were as described under Section 2. (A)
H2O2 : The black bars and hatched bars correspond to the KSCN
and the £uorescence assays, respectively. Concentrations in the reac-
tion solution were 10 WM Cp, 500 WM H2O2, 500 WM GSH, 150
mM NaCl, respectively. (B) LOOH: Reaction solution contained 10
WM Cp, 180 WM LOOH, 500 WM GSH, 150 mM NaCl, respectively.
Data are means þ S.D. of triplicate experiments.
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di¡erence to the removal of LOOH (Fig. 3). Chloride en-
hancement of peroxidase activity was seen only when the
KSCN method was employed to measure H2O2 (Fig. 3) and
did not appear when Amplex Red £uorescence, scopoletin
£uorescence and the titanium colourimetric assays were
used. It, therefore, appears to be an artefact of the KSCN
method. This initial observation led us to consider whether
Cp was exerting a MPO-like activity to produce HOCI (Eq.
1). For Cp, however, no evidence for a catalytic role in HOCI
production was found (Fig. 4).
2H2O2  2GSH 2CI3ÿ!
Cp
2HOCIGSSG 2H2O 1
Normal human plasma contains an EC-GSHPase which
can remove H2O2 (Eq. 2) and LOOH (Eq. 3) when GSH is
present in the low mM concentration range [18].
H2O2  2GSH! GSSG 2H2O 2
LOOH 2GSH! GSSG LOHH2O 3
However, human plasma probably contains less than 1 WM
of GSH [24] which would not support the peroxidase activities
of either EC-GSHPase or Cp. Very recently, peroxiredoxin IV
has been identi¢ed as a secretory protein, with glutathione
peroxidase-like activity, which acts in the extracellular space
[25]. This protein can function at low levels of GSH and may
also contribute to peroxide removal [25].
Previous studies [2,8,9] have shown that Cp is a powerful
plasma antioxidant when iron-stimulated reactions are in-
volved and this has mainly been ascribed to its ferroxidase
activity. Lung lining £uid taken from normal human control
subjects was recently found to contain chelatable redox active
iron [26] that is likely to participate in Eqs. 4 and 5 leading to
the formation of hydroxyl and alkoxyl radicals, respectively.
The combined glutathione peroxidase (Figs. 1 and 2) and
ferroxidase activities (Fig. 5) of Cp would remove the primary
reactants required to drive Fenton chemistry (Eq. 4) and hy-
droperoxide-dependent lipid peroxidation (Eq. 5) and prob-
ably other reactions involving a ferrous salt and organic hy-
droperoxides.
FeII H2O2 ! FeIII  OHOH3 4
FeII  LOOH! FeIII  LO OH3 5
The synthesis of Cp by the lungs would provide a unique
antioxidant that deals with the special problems of the lung.
Thus, in lung lining £uid interactions between high GSH lev-
els, hydrogen peroxide formation by activated phagocytic cells
and low molecular mass iron would be under the control of a
single protein expressed in lung tissue.
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